The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global RNA Analysis Transcriptomics Market Research Report 2024

Global RNA Analysis Transcriptomics Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1805756

No of Pages : 100

Ask Your Query

Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.

Global RNA Analysis Transcriptomics market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole RNA Analysis Transcriptomics market research.

Key companies engaged in the RNA Analysis Transcriptomics industry include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Illumina, QIAGEN N.V., F. Hoffmann-La Roche, Danaher Corporation and Fluidigm Corporation, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of RNA Analysis Transcriptomics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole RNA Analysis Transcriptomics market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global RNA Analysis Transcriptomics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Thermo Fisher Scientific
  •     Bio-Rad Laboratories
  •     Merck KGaA
  •     Agilent Technologies
  •     Illumina
  •     QIAGEN N.V.
  •     F. Hoffmann-La Roche
  •     Danaher Corporation
  •     Fluidigm Corporation
  •     Eurofins Scientific
  •     Sequentia Biotech
  •     Acobiom
  •     GenXPro
  •     CD Genomics
  •     Promega Corporation
  •     Lexogen
  •     Cenix BioScience

Segment by Type

  •     Microarrays
  •     Sequencing
  •     Polymerase Chain Reaction (PCR)
  •     RNA Interference

Segment by Application

  •     Academic & Research Institutes
  •     Pharmaceutical & Biotechnology Companies
  •     Hospitals

By Region

  •     North America (United States, Canada)
  •     Europe (Germany, France, U.K., Italy, Russia)
  •     Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  •     Latin America (Mexico, Brazil, Argentina)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE)

The RNA Analysis Transcriptomics report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global RNA Analysis Transcriptomics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Microarrays
        1.2.3 Sequencing
        1.2.4 Polymerase Chain Reaction (PCR)
        1.2.5 RNA Interference
    1.3 Market by Application
        1.3.1 Global RNA Analysis Transcriptomics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Academic & Research Institutes
        1.3.3 Pharmaceutical & Biotechnology Companies
        1.3.4 Hospitals
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global RNA Analysis Transcriptomics Market Perspective (2018-2029)
    2.2 RNA Analysis Transcriptomics Growth Trends by Region
        2.2.1 Global RNA Analysis Transcriptomics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 RNA Analysis Transcriptomics Historic Market Size by Region (2018-2023)
        2.2.3 RNA Analysis Transcriptomics Forecasted Market Size by Region (2024-2029)
    2.3 RNA Analysis Transcriptomics Market Dynamics
        2.3.1 RNA Analysis Transcriptomics Industry Trends
        2.3.2 RNA Analysis Transcriptomics Market Drivers
        2.3.3 RNA Analysis Transcriptomics Market Challenges
        2.3.4 RNA Analysis Transcriptomics Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top RNA Analysis Transcriptomics Players by Revenue
        3.1.1 Global Top RNA Analysis Transcriptomics Players by Revenue (2018-2023)
        3.1.2 Global RNA Analysis Transcriptomics Revenue Market Share by Players (2018-2023)
    3.2 Global RNA Analysis Transcriptomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by RNA Analysis Transcriptomics Revenue
    3.4 Global RNA Analysis Transcriptomics Market Concentration Ratio
        3.4.1 Global RNA Analysis Transcriptomics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis Transcriptomics Revenue in 2022
    3.5 RNA Analysis Transcriptomics Key Players Head office and Area Served
    3.6 Key Players RNA Analysis Transcriptomics Product Solution and Service
    3.7 Date of Enter into RNA Analysis Transcriptomics Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 RNA Analysis Transcriptomics Breakdown Data by Type
    4.1 Global RNA Analysis Transcriptomics Historic Market Size by Type (2018-2023)
    4.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Type (2024-2029)

 5 RNA Analysis Transcriptomics Breakdown Data by Application
    5.1 Global RNA Analysis Transcriptomics Historic Market Size by Application (2018-2023)
    5.2 Global RNA Analysis Transcriptomics Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America RNA Analysis Transcriptomics Market Size (2018-2029)
    6.2 North America RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America RNA Analysis Transcriptomics Market Size by Country (2018-2023)
    6.4 North America RNA Analysis Transcriptomics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe RNA Analysis Transcriptomics Market Size (2018-2029)
    7.2 Europe RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe RNA Analysis Transcriptomics Market Size by Country (2018-2023)
    7.4 Europe RNA Analysis Transcriptomics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific RNA Analysis Transcriptomics Market Size (2018-2029)
    8.2 Asia-Pacific RNA Analysis Transcriptomics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2018-2023)
    8.4 Asia-Pacific RNA Analysis Transcriptomics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America RNA Analysis Transcriptomics Market Size (2018-2029)
    9.2 Latin America RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America RNA Analysis Transcriptomics Market Size by Country (2018-2023)
    9.4 Latin America RNA Analysis Transcriptomics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa RNA Analysis Transcriptomics Market Size (2018-2029)
    10.2 Middle East & Africa RNA Analysis Transcriptomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2018-2023)
    10.4 Middle East & Africa RNA Analysis Transcriptomics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Detail
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Introduction
        11.1.4 Thermo Fisher Scientific Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Bio-Rad Laboratories
        11.2.1 Bio-Rad Laboratories Company Detail
        11.2.2 Bio-Rad Laboratories Business Overview
        11.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Introduction
        11.2.4 Bio-Rad Laboratories Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.2.5 Bio-Rad Laboratories Recent Development
    11.3 Merck KGaA
        11.3.1 Merck KGaA Company Detail
        11.3.2 Merck KGaA Business Overview
        11.3.3 Merck KGaA RNA Analysis Transcriptomics Introduction
        11.3.4 Merck KGaA Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.3.5 Merck KGaA Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Detail
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies RNA Analysis Transcriptomics Introduction
        11.4.4 Agilent Technologies Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.4.5 Agilent Technologies Recent Development
    11.5 Illumina
        11.5.1 Illumina Company Detail
        11.5.2 Illumina Business Overview
        11.5.3 Illumina RNA Analysis Transcriptomics Introduction
        11.5.4 Illumina Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.5.5 Illumina Recent Development
    11.6 QIAGEN N.V.
        11.6.1 QIAGEN N.V. Company Detail
        11.6.2 QIAGEN N.V. Business Overview
        11.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Introduction
        11.6.4 QIAGEN N.V. Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.6.5 QIAGEN N.V. Recent Development
    11.7 F. Hoffmann-La Roche
        11.7.1 F. Hoffmann-La Roche Company Detail
        11.7.2 F. Hoffmann-La Roche Business Overview
        11.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Introduction
        11.7.4 F. Hoffmann-La Roche Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.7.5 F. Hoffmann-La Roche Recent Development
    11.8 Danaher Corporation
        11.8.1 Danaher Corporation Company Detail
        11.8.2 Danaher Corporation Business Overview
        11.8.3 Danaher Corporation RNA Analysis Transcriptomics Introduction
        11.8.4 Danaher Corporation Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.8.5 Danaher Corporation Recent Development
    11.9 Fluidigm Corporation
        11.9.1 Fluidigm Corporation Company Detail
        11.9.2 Fluidigm Corporation Business Overview
        11.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Introduction
        11.9.4 Fluidigm Corporation Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.9.5 Fluidigm Corporation Recent Development
    11.10 Eurofins Scientific
        11.10.1 Eurofins Scientific Company Detail
        11.10.2 Eurofins Scientific Business Overview
        11.10.3 Eurofins Scientific RNA Analysis Transcriptomics Introduction
        11.10.4 Eurofins Scientific Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.10.5 Eurofins Scientific Recent Development
    11.11 Sequentia Biotech
        11.11.1 Sequentia Biotech Company Detail
        11.11.2 Sequentia Biotech Business Overview
        11.11.3 Sequentia Biotech RNA Analysis Transcriptomics Introduction
        11.11.4 Sequentia Biotech Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.11.5 Sequentia Biotech Recent Development
    11.12 Acobiom
        11.12.1 Acobiom Company Detail
        11.12.2 Acobiom Business Overview
        11.12.3 Acobiom RNA Analysis Transcriptomics Introduction
        11.12.4 Acobiom Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.12.5 Acobiom Recent Development
    11.13 GenXPro
        11.13.1 GenXPro Company Detail
        11.13.2 GenXPro Business Overview
        11.13.3 GenXPro RNA Analysis Transcriptomics Introduction
        11.13.4 GenXPro Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.13.5 GenXPro Recent Development
    11.14 CD Genomics
        11.14.1 CD Genomics Company Detail
        11.14.2 CD Genomics Business Overview
        11.14.3 CD Genomics RNA Analysis Transcriptomics Introduction
        11.14.4 CD Genomics Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.14.5 CD Genomics Recent Development
    11.15 Promega Corporation
        11.15.1 Promega Corporation Company Detail
        11.15.2 Promega Corporation Business Overview
        11.15.3 Promega Corporation RNA Analysis Transcriptomics Introduction
        11.15.4 Promega Corporation Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.15.5 Promega Corporation Recent Development
    11.16 Lexogen
        11.16.1 Lexogen Company Detail
        11.16.2 Lexogen Business Overview
        11.16.3 Lexogen RNA Analysis Transcriptomics Introduction
        11.16.4 Lexogen Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.16.5 Lexogen Recent Development
    11.17 Cenix BioScience
        11.17.1 Cenix BioScience Company Detail
        11.17.2 Cenix BioScience Business Overview
        11.17.3 Cenix BioScience RNA Analysis Transcriptomics Introduction
        11.17.4 Cenix BioScience Revenue in RNA Analysis Transcriptomics Business (2018-2023)
        11.17.5 Cenix BioScience Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock